What the 2023 Merger Guidelines Mean for Dealmakers

The 2023 Merger Guidelines changed how dealmakers should think about antitrust risk, diligence, valuation, and transaction strategy from the first conversation through signing and closing. For founders, investors, private equity sponsors, corporate development teams, and executives, these guidelines are not abstract policy. They affect which deals get challenged, what questions regulators ask, how documents are interpreted, and how early a buyer should begin building its defense. In practical terms, the guidelines explain how U.S. antitrust agencies evaluate mergers under Section 7 of the Clayton Act and related laws. They do not create new statutes, but they do signal enforcement priorities, analytical frameworks, and the kinds of evidence that will carry weight in an investigation or courtroom. That is why this topic matters inside a broader legal, tax, and compliance strategy. A deal that looks attractive on paper can lose value quickly if regulatory exposure is underestimated, if integration plans are premature, or if internal documents frame the transaction as a move to eliminate competition. For dealmakers, compliance and regulatory insight now starts long before Hart-Scott-Rodino filings. It starts with market definition, buyer overlap analysis, labor market implications, platform dynamics, vertical relationships, serial acquisition history, and the quality of the narrative you build around the transaction.

Why the 2023 Merger Guidelines Matter in Real Deals

The most important shift is that the agencies made clear they will look at more than classic head-to-head horizontal overlap. The guidelines address market concentration, potential competition, vertical foreclosure, labor effects, platform control, multi-sided markets, roll-up strategies, minority interests, and patterns of consolidation. In plain language, that means more deals can attract scrutiny, including transactions that might once have been viewed as too small, too indirect, or too operationally complex to raise major concerns. I have seen many founders assume antitrust only matters when two obvious competitors merge. That is no longer a safe assumption. A software platform buying a complementary tool, a sponsor rolling up fragmented providers, or a strategic acquirer buying a fast-growing adjacent player can all trigger meaningful questions.

For dealmakers, the practical impact is straightforward. Regulatory risk now affects timeline, legal budget, integration planning, financing certainty, and purchase price negotiations earlier in the process. If a buyer faces a second request, prolonged investigation, or litigation threat, the value of the business changes in real time. Sellers need to understand whether a buyer is the highest bidder or simply the riskiest bidder. Buyers need to assess not only whether a deal can close, but whether the cost of getting it closed changes the economics. That is why this compliance and regulatory insights hub should be treated as foundational, not optional.

The Core Themes Inside the 2023 Merger Guidelines

The guidelines are organized around several principles, but four themes matter most for practical transaction work. First, the agencies are more skeptical of concentration and market power, especially where market shares are already elevated or where a transaction meaningfully increases concentration. Second, they place heavier emphasis on how a deal may entrench or extend dominance, not just create it. Third, they will look closely at nontraditional theories of harm, including labor market effects, platform dynamics, and serial acquisitions. Fourth, they rely heavily on ordinary-course business evidence, meaning strategy decks, emails, board materials, and diligence notes can become central evidence.

That last point is not theoretical. In litigation and merger investigations, internal documents often matter as much as econometric analysis. If your deal rationale says the target is “our most disruptive rival,” “the only scaled threat in the region,” or “the fastest way to rationalize pricing,” you have created evidence the agencies will use. Smart dealmakers now coordinate antitrust sensitivity into the drafting of board decks, management presentations, quality-of-earnings conversations, and integration plans. That is not about hiding intent. It is about describing the transaction accurately, carefully, and with discipline.

Horizontal, Vertical, and Platform Deals Face Different Questions

Horizontal deals remain the clearest antitrust target because they eliminate direct competition between firms selling similar products or services. Under the 2023 Merger Guidelines, concentration thresholds still matter, and the Herfindahl-Hirschman Index remains part of the screening process. But the agencies emphasize that concentration statistics are not the end of the analysis. They also look at market realities like closeness of competition, switching behavior, barriers to entry, and whether one firm has been a particularly important competitive constraint on the other.

Vertical deals, where companies operate at different levels of the supply chain, also face substantial scrutiny. A buyer may own distribution, inputs, data, or platform access that rivals need. The agencies will ask whether the combined company can foreclose competitors, raise their costs, or gain access to competitively sensitive information. This matters in sectors like healthcare, software, logistics, manufacturing, and digital commerce. A transaction that once seemed efficient because it integrated operations may now require a much stronger explanation of why it does not disadvantage rivals.

Platform and ecosystem transactions may be the most nuanced category. The guidelines show particular concern with deals involving dominant platforms, gatekeepers, or businesses operating in multi-sided markets. If one company controls user access, discovery, distribution, or data flows, the agencies may view an acquisition as a way to entrench power even if the target is not a direct substitute. This is especially important for software, marketplaces, adtech, creator economy infrastructure, and AI-enabled workflows.

Roll-Ups, Serial Acquisitions, and Private Equity Strategy

One of the most important sections for sponsors and acquisitive strategics is the focus on patterns of serial acquisition. The agencies signaled they may evaluate a transaction not only on a standalone basis, but in the context of a broader acquisition strategy. That matters for fragmented industries where buyers pursue repeated add-ons to build scale. Healthcare, veterinary services, home services, industrial distribution, software, and business services are obvious examples. The old assumption that many small acquisitions avoid deep scrutiny simply because each deal alone looks modest is less reliable now.

For private equity firms, this does not mean roll-ups are off the table. It means the compliance burden is higher. Buyers should maintain a coherent market map, understand local and national overlap, assess labor concentration, and document procompetitive rationales beyond “buy and consolidate.” Sellers considering PE-backed buyers should evaluate whether a sponsor’s broader platform creates additional risk that could delay or derail closing. In real deal work, I would rather know that before signing than discover it after exclusivity starts.

Labor Markets Are Now a Front-and-Center Antitrust Issue

A major takeaway from the 2023 Merger Guidelines is that labor is no longer a side note. The agencies explicitly state that mergers can harm competition for workers, not just customers. That means they may examine whether a transaction reduces competition in hiring, depresses wages, limits mobility, or weakens working conditions. This matters in industries with specialized labor pools, regional concentration, or a small number of meaningful employers. Healthcare, engineering, skilled trades, logistics, and software development are obvious areas where labor overlap can become material.

Dealmakers should treat labor analysis as part of diligence, not an HR afterthought. Ask where the companies recruit, which roles are difficult to fill, whether labor is local or national, and how compensation compares across competitors. If the strategic logic assumes “synergies” through overlapping teams, be careful how that is framed. Agencies may interpret those assumptions as evidence that the deal reduces competition for employees. That does not mean workforce synergies are forbidden. It means they must be handled with precision and legal awareness.

How the Guidelines Change Diligence and Deal Process

The best response to the 2023 Merger Guidelines is not panic. It is earlier, better discipline. Regulatory analysis should begin in the target-screening stage. Before signing an LOI, buyers should understand overlap, likely market definition arguments, entry barriers, customer alternatives, labor impacts, and prior acquisition history. That level of preparation influences whether you bid, how much you bid, and what closing conditions you require.

Sellers should also adapt. If multiple buyers are in the process, antitrust risk can materially affect deal certainty. The highest price is not always the best offer if the buyer is likely to face a prolonged challenge. That is why sellers should evaluate reverse termination fees, antitrust covenants, “hell or high water” obligations, outside dates, and cooperation commitments with serious attention. Regulatory complexity should be priced into the process just like financing risk or earnout uncertainty.

Internal preparation matters too. Make sure management knows that ordinary-course documents may be reviewed. Avoid sloppy statements that imply the transaction is about neutralizing a rival. Centralize communications. Involve antitrust counsel early. Keep integration planning clean and compliant, especially before clearance. Gun-jumping remains a real risk, and over-eager collaboration before closing can create separate enforcement issues.

What This Means for Valuation, Structure, and Negotiation

One mistake founders and executives make is treating antitrust as a post-signing legal issue. In practice, it affects valuation from the start. If a buyer has meaningful regulatory risk, the expected value of the deal is lower unless the documents shift that risk back to the buyer. That is why sophisticated sellers compare not just headline price, but certainty-adjusted value. A slightly lower bid from a clean buyer may be superior to a higher bid from a buyer facing substantial scrutiny.

Structure matters here. Stronger antitrust covenants, meaningful reverse breakup fees, shorter outside dates, and clear obligations to litigate or divest can all change the economics. So can rollover equity, deferred payments, or earnouts if closing gets delayed. Founders should ask hard questions: How exposed is this buyer? What is its acquisition history? Has it been through second requests before? Is it financially and operationally prepared for a long review? These are compliance and regulatory questions, but they are also negotiation questions.

How This Hub Connects to the Broader Compliance and Regulatory Landscape

This article is the hub for compliance and regulatory insights because merger guidelines do not operate in isolation. Real transactions intersect with Hart-Scott-Rodino filing strategy, gun-jumping rules, labor and employment law, privacy and data governance, sector-specific approvals, tax structuring, and post-close integration compliance. In other words, antitrust is one piece of a broader risk map. If you are preparing for an eventual sale, the right move is to build this thinking into your operating discipline now.

That is why founders should not wait until a buyer appears to get educated. Start building the habits now: clean records, disciplined communications, clear market positioning, and documented processes. If you want a practical framework for that broader preparation process, The Entrepreneur’s Exit Playbook explains how to start building toward readiness long before the deal arrives. You can find it here: https://amzn.to/3NOnNVH. For more transaction-focused insight and related M&A education, explore Legacy Advisors.

What Dealmakers Should Do Next

The 2023 Merger Guidelines mean dealmakers need to elevate regulatory thinking from a legal checkbox to a core strategic function. The agencies are looking more broadly, more skeptically, and more holistically at competition issues across products, platforms, labor, and acquisition patterns. That does not mean good deals stop happening. It means the winners will be the founders, executives, and investors who prepare earlier, document better, and negotiate from a position of informed discipline. If you are building, acquiring, rolling up, or planning to exit, treat compliance and regulatory insight as part of value creation itself. Review your acquisition strategy. Pressure-test your buyer list. Align your internal narrative. Build a team that understands not just how to get a deal signed, but how to get it closed. Then keep going deeper into the rest of this compliance and regulatory hub, because the best outcomes come from preparation, not reaction.

Frequently Asked Questions

What do the 2023 Merger Guidelines change for dealmakers in practical terms?

The biggest practical change is that antitrust analysis now needs to start much earlier and reach much further into the life of a transaction. The 2023 Merger Guidelines do not create entirely new law, but they do show how enforcement agencies are likely to investigate, frame theories of harm, and evaluate evidence. For dealmakers, that means antitrust risk is no longer something to assess only after a letter of intent is signed or when Hart-Scott-Rodino filing work begins. It should be part of target screening, valuation, diligence planning, transaction structuring, and communications strategy from the outset.

In real-world terms, buyers should expect regulators to look beyond narrow market-share snapshots and ask broader questions about competition, market structure, customer dependence, entry barriers, vertical relationships, serial acquisitions, platform dynamics, labor effects, and whether the deal could entrench an already strong position. Agencies may also place greater weight on internal documents, strategic plans, banker materials, board decks, and ordinary-course emails that describe the rationale for the deal. That matters because a transaction that appears manageable under a traditional concentration analysis can become much riskier if the parties’ own documents suggest the acquisition removes a disruptive rival, strengthens control over a key channel, or helps dominate an ecosystem.

For founders, sponsors, and corporate acquirers, the takeaway is straightforward: build antitrust thinking into the deal process before the process builds risk into the deal. That includes identifying the likely regulatory narrative early, pressure-testing whether the target is seen as a current or future competitive threat, and understanding whether transaction documents, management presentations, and synergy claims are consistent with the legal story the parties may need to tell later. The guidelines make preparation, discipline, and alignment across legal, business, and finance teams much more important.

How should buyers adjust diligence under the 2023 Merger Guidelines?

Diligence should become more targeted, more strategic, and more closely integrated with antitrust counsel. Under the 2023 framework, buyers should not limit diligence to overlapping products and revenue lines. They should also examine customer segments, adjacent markets, pipeline products, data advantages, network effects, labor markets, distribution channels, exclusivity arrangements, ownership of critical inputs, and whether either party is positioned as a particularly disruptive or fast-growing competitor. Even if today’s overlap appears modest, regulators may focus on future competition, ecosystem effects, or the practical ability of the combined company to disadvantage rivals.

A useful diligence process now asks several layers of questions. First, where do the parties compete directly today, and how concentrated are those spaces? Second, where could they compete tomorrow based on product roadmap, hiring, R&D, partnerships, or customer expansion plans? Third, do vertical or platform relationships give the combined firm a new ability or incentive to foreclose, steer, bundle, discriminate, or raise rivals’ costs? Fourth, how would customers, suppliers, employees, and channel partners describe the competitive significance of each company? Those outside perspectives often matter because agencies regularly test the parties’ internal narratives against market testimony.

Document diligence also deserves special attention. Internal materials should be reviewed not just for legal disclosure, but for language that may be misread or used to support an enforcement theory. Statements such as “buy rather than compete,” “control the category,” “lock in distribution,” or “neutralize a future threat” can create avoidable complications if they are not carefully contextualized. The goal is not to rewrite history, but to understand the evidentiary record early enough to prepare an accurate and credible explanation. Thorough diligence under the new guidelines helps buyers decide whether to proceed, reprice, restructure, or build a stronger advocacy case well before filing.

Do the 2023 Merger Guidelines affect valuation and deal pricing?

Yes, and often more than parties initially expect. The guidelines can influence valuation because antitrust risk affects the probability, timing, cost, and ultimate economics of getting a deal closed. A transaction with meaningful regulatory exposure may require a longer signing-to-closing period, more extensive document production, substantial management distraction, outside economic analysis, divestiture planning, or litigation readiness. Each of those factors can reduce the present value of the deal or change the price a buyer is willing to pay. In some cases, the issue is not whether the target is attractive, but whether the risk-adjusted path to ownership still supports the headline valuation.

Buyers and sellers should also think about how antitrust uncertainty interacts with conditionality. Reverse termination fees, hell-or-high-water covenants, divestiture commitments, cooperation obligations, timing extensions, and control of the defense strategy all have economic value. The more uncertain the regulatory path, the more those terms function as pricing mechanisms. A buyer that cannot confidently underwrite a prolonged investigation may seek a lower purchase price or more flexible commitment language. A seller facing a concentrated buyer universe may demand stronger closing protections in exchange for exclusivity. In that sense, the guidelines affect not just valuation in a spreadsheet, but the entire allocation of execution risk across the purchase agreement.

Another important pricing issue is strategic optimism. Some buyers historically underwrote transactions on the assumption that antitrust review would remain relatively narrow or heavily settlement-oriented. The 2023 Merger Guidelines make that assumption less reliable. Sponsors, boards, and investment committees should therefore incorporate more realistic downside scenarios into valuation models, including extended review periods, conduct restrictions during the interim period, remedy uncertainty, and the possibility that the best transaction structure may be one that preserves optionality rather than maximizes immediate scale. Strong dealmakers now treat antitrust as a core underwriting variable, not a legal footnote.

What kinds of deals are more likely to draw scrutiny under the 2023 Merger Guidelines?

Deals are more likely to attract scrutiny when they can be framed as strengthening concentration, eliminating an important rival, entrenching an already powerful firm, or creating new ways to disadvantage competitors. That includes classic horizontal combinations between significant competitors, but it also extends to acquisitions involving nascent threats, dominant platforms, critical suppliers, major distributors, firms with strong network effects, and repeat acquirers pursuing a pattern of consolidation. Agencies may also focus on whether a transaction could reduce competition for workers, diminish innovation incentives, or give the combined company leverage over access points that others depend on.

In practical terms, a deal may face higher risk even if market shares alone do not appear overwhelming. For example, regulators may care that the target is a uniquely innovative entrant, a low-price disruptor, a fast-scaling software provider, or a company that constrains the buyer in bidding situations despite a small current revenue base. Likewise, vertical transactions can raise concerns if they combine a firm with market power and a critical input, customer base, dataset, or distribution channel that rivals need to compete effectively. The guidelines support a more fact-intensive and narrative-driven review, which means the agencies may challenge transactions that once might have been viewed as less controversial.

That does not mean every ambitious deal is blocked or that every concentrated industry is off limits. It means parties need a more disciplined assessment of what story the transaction tells. If the likely agency narrative is that the buyer is absorbing a threat, controlling a bottleneck, or reinforcing a dominant position, the deal team should assume scrutiny will be serious and prepare accordingly. Early candid risk assessment is far better than late surprise after strategic momentum, financing commitments, and public messaging make course correction difficult.

How can dealmakers better prepare for regulatory review and improve the chances of closing?

Preparation starts with building the defense before regulators ask for it. The most effective deal teams develop a coherent competitive narrative early, supported by ordinary-course facts, customer realities, economic evidence, and disciplined transaction documents. That means identifying the procompetitive rationale for the deal, understanding where the agencies are likely to probe, and making sure leadership, bankers, consultants, and counsel are aligned on the same factual story. If the business rationale is innovation, expanded output, better service, or accelerated product development, the parties should be prepared to show specifically how and why, not just state it in general terms.

Another critical step is document discipline. Regulators will study emails, board materials, market analyses, synergy models, and deal presentations closely. Companies should not manufacture favorable language, but they should avoid careless shorthand that oversimplifies competitive intent. Teams should also organize data early, map key custodians, understand product overlaps, and anticipate customer and competitor feedback. If labor markets, pipeline products, switching costs, or channel access could become issues, those topics should be analyzed before filing, not after a second request or an in-depth investigation arrives.

Transaction structure and process design also matter. Parties may improve execution odds by choosing structures that reduce unnecessary overlap, carefully defining interim operating covenants, allocating regulatory risk explicitly in the agreement, and setting realistic timelines with financing sources and boards. In higher-risk situations, some buyers benefit from an early advocacy plan that includes economist support, industry context, and a clear explanation of why the deal will not lessen competition. The central lesson of the 2023 Merger Guidelines is that regulatory review is no longer a downstream administrative step. For many transactions, it is a core strategic workstream that can shape whether the deal is signed, how it is priced, and whether it closes at all.